Find uplifting stories about heroes, innovations, and solutions
8784 results for "nhs treatment approval"
Patients in England with advanced gastrointestinal stromal tumors now have a fourth treatment option after NHS approved ripretinib, a drug that extends life with fewer side effects. For those who've exhausted all other therapies and faced weeks to live, this approval brings genuine hope.
Around 20 people in England with a debilitating genetic condition can now access the first treatment that targets the root cause of their disease. The NHS will provide pegzilarginase to patients with arginase-1 deficiency after breakthrough approval.
Boys living with Duchenne muscular dystrophy in England now have access to a new treatment that could extend their ability to walk by up to five years. The NHS has approved givinostat, offering fresh hope to families facing this devastating muscle-wasting disease.
After two decades without a breakthrough, England's health service has approved a targeted therapy that offers new hope to women with hard-to-treat ovarian cancer. Around 400 patients annually will now access this "biological missile" treatment that doubles as their first option when chemotherapy stops working.
Hundreds of women with hard-to-treat ovarian cancer will now receive a groundbreaking new therapy that extends life while dramatically reducing the debilitating side effects of traditional chemotherapy. The approval marks the first new ovarian cancer treatment on the NHS in two decades.
The FDA just approved Optune Pax, a new treatment option for people battling locally advanced pancreatic cancer. This approval brings fresh hope to patients facing one of the most challenging cancer diagnoses.
Nearly 30,000 people in England with chronic lung disease will gain access to the first treatment that targets an underlying cause, not just symptoms. The twice-monthly injection cuts severe flare-ups by 30% and could save the NHS millions.
The FDA just approved two new treatment combinations for cancer patients who've run out of options. These approvals bring fresh hope to people battling mantle cell lymphoma.
A groundbreaking treatment can now delay type 1 diabetes for up to three years, giving families precious time before symptoms begin. The NHS has approved the first-ever drug that stops the disease in its tracks during early stages.
After years without any approved therapies, adults living with chronic hepatitis delta virus now have hope with the FDA's approval of Hepcludex, the first treatment for one of the most severe forms of viral hepatitis. This breakthrough fills a critical gap for nearly 200,000 Americans who face rapid progression to serious liver complications.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
A new immunotherapy drug for aggressive stomach cancer just got the green light from the NHS, marking the first major treatment breakthrough in nearly ten years. About 1,500 people a year in the UK will now have access to a therapy that extends survival and reduces cancer recurrence.
A new high dose version of an SMA treatment just won FDA approval, offering faster results for babies and children fighting this devastating muscle disease. The breakthrough gives families a more powerful option against a condition that once had no treatment at all.
People with a rare lung disease now have access to a more affordable treatment option after the FDA approved the first generic version of a life-changing medication. The new approval could help thousands of patients breathe easier, both physically and financially.
A new, stronger version of the popular weight loss medication Wegovy just got FDA approval, giving more Americans access to potentially more effective obesity treatment. The approval came through a new fast-track program designed to speed up medicines that address major health priorities.
The UAE just became the first country in the world to approve a groundbreaking blood pressure treatment and the first in its region to greenlight a needle-free rescue spray for severe allergies. These approvals cement the nation's position as a global leader in getting life-changing medicines to patients fast.
A Minnesota company just won FDA approval for a breakthrough prostate cancer treatment that uses steam instead of surgery. The 30-minute outpatient procedure could help 84% of newly diagnosed patients avoid invasive treatments.
Women with triple-negative breast cancer just gained two powerful new treatment options that work better than standard chemotherapy at keeping the disease under control. The FDA approved Trodelvy alone and combined with immunotherapy as first-line treatments for this aggressive cancer type.
The NHS just approved a groundbreaking ovarian cancer treatment that works like a guided missile, targeting only cancer cells while leaving healthy tissue untouched. For women with platinum-resistant ovarian cancer who had almost no options left, this precision medicine marks a genuine turning point. #
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
Showing 20 of 8784